Metraipolis › archive › dc_c3c5f2dadbb9

TROP2: as a promising target in lung cancer — Europe PMC PMID:40936682

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40936682
DOI
10.3389/fonc.2025.1569897
License (as archived)
solo-consultazione
Archived
2026-11-10T07:44:46.677Z
SHA-256 of the archived text
12b921a310b42d494499ed8b938dba6762d36ec6386a951c68eac409bd8e9a1a
Stable URL of this page
https://metraipolis.com/documento/dc_c3c5f2dadbb9

How to cite

TROP2: as a promising target in lung cancer — Europe PMC PMID:40936682 — Europe PMC (en), https://europepmc.org/article/MED/40936682 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c3c5f2dadbb9 (Metraipolis archive dc_c3c5f2dadbb9, sha256 12b921a310b42d494499ed8b938dba6762d36ec6386a951c68eac409bd8e9a1a)
BibTeX
@misc{dcc3c5f2dadbb9,
  title = {TROP2: as a promising target in lung cancer — Europe PMC PMID:40936682},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40936682},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c3c5f2dadbb9; sha256 12b921a310b42d494499ed8b938dba6762d36ec6386a951c68eac409bd8e9a1a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936682. Agents can read the archived copy with the MCP tool read_document.